The table below shows REPLIGEN CORP's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$28.30M
$15.01M
$44.71M
$11.15M
$23.11M
$9.26M
Capital expenditure
$4.71M
$3.56M
$8.35M
$8.51M
$27.20M
$7.58M
Investing cash flow
-$3.99M
-$74.11M
-$8.36M
-$9.43M
-$28.21M
-$9.00M
Dividends paid
-
-
-
-
-
RGEN operating cash flow (10-K history)
REPLIGEN CORP reported operating cash flow of $117.42M for fiscal year 2025. That is down 33.1% from $175.39M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $7.52M (FY 2016) to $117.42M. Figures come from the company's audited annual reports as filed with the SEC.
